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Abstract
Combinations of progesterone, lutenizing hormone releasing hormone analogue (LHRHa), human
chorionic gonadotrophin (hCG), and the dopamine-2 (DA2) receptor antagonist 1-[1-[4,4-bis(4-
Fluorophenyl)butyl]-4-piperidinyl]-1,3-dihydro-2H-benzimidazol-2-one (Pimozide; Orap) were
tested for improvement of spawning rates, oocyte numbers, fertilization and neurulation rates of
the Fowler toad (Bufo fowleri). Only treatments combined with progesterone produced large
numbers of oocytes. The best treatment on oocyte numbers, neurulation rates, and the number of
neurulas was with 5 mg progesterone, 20 mic.g LHRHa, and 0.25 mg Pimozide. Progesterone (5
mg) with 60 mic.g LHRHa gave high spawning rates, oocyte numbers, and fertilization rates but
neurulation rates were low. Progesterone alone in high repeated doses did not result in ovulation.
High doses of LHRHa (60 mic.g) with hCG, progesterone, and Pimozide gave the greatest number
of toads spawning, however, they resulted in low oocyte numbers, fertilization and neurulation
rates. A low dose of LHRHa (4 mic.g) with hCG, or hCG alone as a second administration, and
progesterone with Pimozide produced few good quality oocytes. Toads were given normal
ovulatory doses of hormones 24 or 48 hrs after their initial dose, but these resulted in low oocyte
numbers followed by poor fertilization. Overall, these results suggest that progesterone with a
dose between 20 mic.g and 60 mic.g of LHRHa may be optimal for the induction of ovulation in
these toads. Moreover, Pimozide can supplement low doses of LHRHa but not replace it.
Background
Captive breeding and genetic resource banking [1,2] are
necessary to maintain the viability of the approximately
32% of the worlds amphibian species that are endangered
or threatened [3]. The efficient use of captive breeding and
genetic resource banks requires the reliable production of
oocytes, usually through hormonal induction [1]. The use
of either pituitaries or hormone analogues to induce ovu-
lation of amphibians is well established in a few labora-
tory species of anurans including the African clawed toads
(Xenopus spp.), northern leopard frogs (Rana pipiens), and
the wood frog (Rana sylvatica) [4,5]. Unfortunately, these
established protocols for hormonal induction are often
species-specific [5,6], vary with the seasonal maturation of
females [7,8], or with husbandry conditions [9] and are
limited in their application. Considering that amphibians
have a high diversity of reproductive strategies it would be
expected that their physiological responses to induction
protocols would be correspondingly diverse [10]. Conse-
quently, there is a need to increase the reliability of proto-
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cols using hormones for the induction of ovulation in
amphibians and to extend the range of these protocols to
novel species [1,10].
The two common hormones used to induce ovulation in
anurans are human chorionic gonadotrophin (hCG) and
luteinizing hormone releasing hormone analogue
(LHRHa) [10]. In Xenopus spp. hCG is reliable in inducing
ovulation, however, it is successful only in a minority of
other species [11]. LHRHa as an ovulatory agent has
proven more universal among amphibians by stimulating
leutinizing hormone release from the pituitary which
then results in ovulation and spawning [12]. Of the vari-
ous forms of LHRHa the synthetic hormone D-Ala6, des-
Gly10, ethylamide LHRHa has proved superior to mam-
mal, avian, or fish LHRHa [10].
The ability of single doses of hormones to ovulate anurans
is dependent on the presence of mature follicles. These
mature follicles are only found in anurans after specific
environmental conditions [10]. We have recently com-
pleted studies that showed in the Wyoming toad (Bufo
baxteri) that the sequential administration of a combina-
tion of hCG and LHRHa a week prior to ovulation
resulted in increased numbers of spawning toads, oocyte
numbers, fertilization and neurulation rates [unpublished
data]. In addition, both in-vitro [13,14] and in-vivo [15]
studies of the long-term administration of progesterone
have increased the number of mature oocytes and their
fertility [16,17]. In nature progesterone is released by the
follicles to mature stage IV oocytes. This response is also
promoted by the artifical application of hCG, or gona-
dotrphin releasing hormone GnRH produced in response
to elevated levels of LHRH [10].
There have been a number of other compounds, in com-
bination with reproductive hormones, used to improve
oocyte production and quality in fish, including anti-
dopaminergic compounds and saccharides [18,19]. The
central dopaminergic system is an important inhibitory
component in the regulation of LHRH by the brain [20].
Studies in fish have shown that stress-induced corticoster-
oids can inhibit the release of gonadotropin to the extent
that administration of the dopamine-2 (DA2) receptor
antagonist Pimozide™ is needed to achieve high rates of
ovulation and oocyte quality [18,20-22]. In Catfish (Het-
eropneustes fossilis), the use of Pimozide™ in the early
spawning phase potentiated the otherwise anovulatory
dose of 0.05 g GnRH analogue to induce aseasonal ovula-
tion [20]. The mechanism of this response was further
studied in the goldfish where Pimozide™ caused increases
in serum gonadotropin levels and accumulation of GnRH
in the pituitary. This response was inhibited by the cen-
trally active dopaminergic agonist apomorphine [22]. The
use of Pimozide™ could also have similar beneficial effects
on ovulation rates in captive anurans.
The purpose of this study was to test the ovulatory
response, and subsequent spawning, fertilization and
neurulation rates of B. fowleri stimulated with combina-
tions of progesterone, hCG, LHRHa, and Pimozide™.
Methods
Animals
Male and female B. fowleri were collected in Memphis,
Tennessee, USA, (35°15'N,90°05'W) in late July 2005. B.
fowleri naturally spawn in Memphis from May through
July. Toads were housed in 50 × 40 × 10 cm plastic boxes
with a substrate of 25 mm thick sponge matting and a
piece of cork bark for shelter with a water bowl at one end.
The tanks were washed three times weekly, and the toads
fed enriched and Reptivite™ (Zoo Med, San Luis Obispo,
CA, USA) vitamin supplemented mealworms [23]. The
toads were randomly assigned to different treatments and
there was no significant (P < 0.05) difference in weight or
length of female toads between treatments (pooled
weight n = 47, 32.8 ± 1.7, mean ± SD).
Hormonal induction of spermiation
To induce spermiation, ten male toads were administered
a dose of 300 IU of hCG (Sigma-Aldrich, St. Louis, C-
1063) dissolved in 100 µl of reagent grade water by injec-
tion in the intra-peritoneal cavity. The toads were then
placed individually in 3.8 L plastic boxes with 1 cm of tap
water. The water was changed if soiling was apparent. To
collect spermic urine, toads were carefully removed from
their box and superficial water dried with a tissue. The
toads were then held by a thumb and index finger, ante-
rior and across the pelvic girdle, above a 150 mm diameter
Petri dish. Gentle massaging then promoted urination,
usually within 60 sec. Spermic urine was stored in an ice
slurry at 0°C until use [24].
Hormonal induction of spawning and the in-vitro 
fertilization of eggs
Female toads were randomly divided into seven treatment
groups with seven animals per treatment except one group
of five. Each treatment group was administered a different
combination of hormones and Pimozide™ as outlined in
table one. Twenty four or forty-eight hours after the first
dose a second dose of hormones were administered to see
if further oocyte production could be achieved (Table 1).
The hormones tested in various combinations included
hCG (Sigma-Aldrich, St. Louis, C-1063), D-Ala6, des-
Gly10, ethylamide LHRHa (Sigma-Aldrich, St. Louis,
L4513), progesterone (Sigma-Aldrich, St. Louis, P8783),
and the anti-dopaminergic compound 1-[1-[4,4-bis(4-
Fluorophenyl)butyl]-4-piperidinyl]-1,3-dihydro-2H-ben-
zimidazol-2-one (Pimozide™; Orap®; Sigma-Aldrich, St.Reproductive Biology and Endocrinology 2006, 4:3 http://www.rbej.com/content/4/1/3
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Louis, P1793). All the combinations of hormones or
Pimozide™ were administered through intra-peritoneal
injection in 100 µl of phosphate buffered saline (PBS)
(Intervet, Millsboro, De 19966, USA) except for those
containing progesterone which were administered in 1 ml
of PBS. The doses of compounds per. gram of frog weight
are listed in Table 2.
Animals from all treatment groups were placed individu-
ally into single 11.4 L plastic boxes containing 1.5 cm of
Simplified Amphibian Ringer solution (SAR; 6.6 gl-1
NaCl, 0.147 gl-1 CaCl2, 0.149 gl-1 KCl, 0.302 gl-1 NaHCO3;
220 mOsmol kg-1; [25]) to lengthen the time the eggs
would remain fertilizable. The SAR was changed if soiling
was apparent. The presence of eggs was then monitored
for 24 hrs after injection. After spawning, individual
strings of oocytes containing 20 to 30 oocytes were sepa-
rated into replicates totaling 150–250 oocytes and placed
in separate Petri dishes. Approximately 100 µl of urine
containing sperm samples of good motility and concen-
tration were then pipetted and gently mixed into the
oocytes. The oocytes and sperm were allowed to co-incu-
bate for 10 minutes before flooding the dishes with water.
Fertilization rates were tested 6 to 8 hrs post fertilization
at larval stage 3–6 Daudin, 1956 [26]. Counts of fertilized
eggs and unfertilized oocytes, and neurulas were taken
under stereo dissecting microscope (Omano™) and fertili-
zation or neurulation (stage 26–28 Daudin, 1956) rates
(%) calculated.
Results and discussion
This study investigated spawning rates, oocyte numbers,
and fertilization and neurulation rates of B.  fowleri  in
response to stimulation with various combinations of the
three hormones, progesterone, LHRHa, hCG and with the
hormone agonist Pimozide™ (Table 3,4). Repeated doses
of progesterone alone or 20 µg LHRHa alone did not pro-
mote a spawning response in any toads. The normal ovu-
latory dose of 500 IU hCG even when supplemented with
4 µg LHRHa only promoted spawning in two toads and
20 µg of LHRHa plus Pimozide™ only promoted spawn-
ing in one toad. Spawning rates above 50% were only
found in treatments containing progesterone. For hor-
mone treatments containing progesterone, spawning
occurred in 58–85% of the toads. However, progesterone
alone in repeated doses did not result in ovulation, show-
ing that under these circumstances progesterone is not an
ovulatory hormone. The best response of oocyte numbers
per. spawning toad was with 5 mg progesterone, 20 µg
LHRHa, and 0.25 mg Pimozide™ (2486 ± 825). This
number of oocytes was not significantly different (P < 0.5)
from 5 mg progesterone with 60 µg LHRHa (2004 ± 196)
or progesterone, 60 µg LHRHa, Pimozide™, and 500 IU
hCG (1078 ± 502)(means ± SE). Therefore, treatments
with progesterone and an ovulatry hormone gave the
highest number of oocytes per. spawning toad. Conse-
quently, progesterone appeared to synergize with LHRHa
to promote spawning and to increase oocyte numbers.
Only treatments with LHRHa (20 µg or more) plus
another hormone resulted in fertilized eggs. The treat-
ment of 5 mg progesterone with 60 µg LHRHa gave a sig-
nificantly (P < 0.05) higher percentage of fertilized eggs
Table 1: Toads were randomly placed into seven treatments where hormones were administered alone or in variouscombinations. 
Treatment 7* was administered two doses of progesterone 12 hrs apart. Then all seven treatments were administered a second dose 
of compounds either 24 or 48 hrs later and evaluated as a second set of treatments (8–14).
Treatment No. of 
animals
Hormones administered (First combination) Period (hrs) Treatment Hormones administered 
(Second combination)
1 7 500 IU hCG + 4 µg LHRHa 24 8 500 IU hCG + 4 µg LHRHa
27 2 0   µg LHRHa 24 9 60 µg LHRHa
37 2 0   µg LHRHa + 0.25 mg Pimozide™+ 5 mg progesterone 24 10 60 µg LHRHa
47 2 0   µg LHRHa + 0.25 mg Pimozide™ 24 11 60 µg LHRHa
57 6 0   µg LHRHa + 5 mg progesterone 24 12 60 µg LHRHa
67 6 0   µg LHRHa + 5 mg progesterone + 0.25 mg Pimozide™ + 500 
IU hCG
24 13 500 IU hCG
7* 5 5 mg progesterone > 12 h r > 5 mg progesterone 48 14 60 µg LHRHa
Table 2: The different doses of hormones or Pimozide™ used in 
this study and the amountper. gram of toad weight.
Compound Administered dose Amount per gram of toad weight
hCG 500 IU hCG 15 IU
LHRHa 4 µg0 . 1 2   µg
LHRHa 20 µg0 . 6 1   µg
LHRHa 60 µg 1.8 µg
Progesterone 5 mg 0.15 mg
Pimozide™ 0.25 mg 0.0076 mgR
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Table 3: Variables measured in response to different hormone treatments including toad length, weight, the number and percentage of spawning toads, the number of oocytes, 
percent fertilization, number of neurulas, percent neurulation, and total number of neurulas. Treatment 7* was administered two doses of progesterone 12 hrs apart. Data in 
the table are expressedas Means ± SE and ranges of spawning toads.
Treatment Treatment Length (mm) Weight (g) No. and percent 
of toads 
spawning
No. oocytes per. 
spawning toad
Total 
oocytes
Percent 
fertilization
Neurulas Percent 
neurulation
Total 
neurulas
15 0 0  I U  h C G  +  4  µg LHRHa 63.5 ± 6.7 48.0 ± 18.0 (2/7) 29% 2283 ± 269 4566 0% 0 0% 0
22 0   µg LHRHa 69.4 ± 8.5 50.2 ± 17.9 (0/7) 0% NA 0 NA NA NA NA
32 0   µg LHRHa + 0.25 mg 
Pimozide™ + 5 mg 
progesterone
70.0 ± 8.0 48.8 ± 11.4 (4/7) 58% 2486 ± 825 
(350–4140)
9944 35 ± 11% 
(0–69%)
546 ± 60 
(0–1131)
22 ± 12% 
(0–53%)
2184
42 0   µg LHRHa + 0.25 mg 
Pimozide™
65.9 ± 4.5 43.5 ± 5.7 (1/7) 14% 627 627 34% 157 25% 157
56 0   µg LHRHa + 5 mg 
progesterone
67.1 ± 4.7 46.0 ± 6.1 (5/7) 71% 2004 ± 196 
(1489–2625)
10020 73 ± 5% 
(57–89%)
378 ± 106 
(0–1081)
19 ± 11% 
(0–60%)
1890
66 0   µg LHRHa + 5 mg 
progesterone + 0.25 mg 
Pimozide™ + 500 IU hCG
65.1 ± 5.0 43.2 ± 7.2 (6/7) 85% 1078 ± 502 
(80–3470)
6468 20 ± 8% 
(0–47%)
129 ± 31 
(0–178)
12 ± 5% 
(0–34%)
774
7* 5 mg progesterone then after 
12 hrs another 5 mg 
progesterone
64.0 ± 2.8 40.0 ± 5.3 (0/5) 0% NA 0 NA NA NA NAReproductive Biology and Endocrinology 2006, 4:3 http://www.rbej.com/content/4/1/3
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(73 ± 5%) than either of the other treatments with proges-
terone; progesterone with 20 µg LHRHa, and Pimozide™
(35 ± 11%); or progesterone with 60 µg LHRHa, Pimoz-
ide™, and 500 IU hCG (20 ± 8%)(means ± SE). LHRHa
without progesterone resulted in the spawning of only
one toad with a fertilization rate of 34%. All the treat-
ments with Pimozide™ produced oocytes. However, pro-
gesterone with 20 µg LHRHa yielded a greater percentage
of fertilized eggs than the same treatment with Pimoz-
ide™. Hence, the ability of Pimozide™ to improve the hor-
monal induction of anurans is uncertain.
Neurulation rates did not correspond with fertilization
rates. The treatment with progesterone and 60 µg LHRHa
had the highest fertilization rate (73 ± 5%) but the neuru-
lation rate was similar (19 ± 11%) to that from progester-
one, 20 µg LHRHa, and Pimozide™ (22 ± 12%). The
highest total number of neurulas (2184) was produced
from progesterone, 20 µg LHRHa, and Pimozide™. These
results indicate that the effect of Pimozide™ on the differ-
ent stages of spawn rate, oocyte numbers, fertilization
rate, and neurulation rate are inconsistent. Nevertheless,
the use of Pimozide™ with progesterone did result in the
highest number of neurulas.
Toads were given a normal ovulatory dose of hormones
24 or 48 hrs after their initial dose, but these resulted in
zero or few oocytes produced of low quality (Table 4).
These results correspond with others where a second dose
from 24 to 48 hrs is seldom successful [[10], Browne et al.,
unpublished data].
From the results of previous studies, the inability of hCG
and LHRHa without progesterone, to induce substantial
numbers of oocytes or high fertilization and neurulation
rates suggests that the B. fowleri in this study did not ini-
tially possess many oocytes at a suitable stage for immedi-
ate maturation [27,28]. The females in this study were all
above the minimum spawning size for B. fowleri and were
captured at the end of the breeding season in Memphis.
Thus, it is probable that many if not all of these toads that
were capable of spawning had done so. Studies have
shown that previtellogenic oocytes (stage I, II) exist in
anurans throughout the year and quickly mature to stage
IV oocytes prior to ovulation [27,28]. Immediately after
spawning, the stage IV oocytes decline in numbers and
require several months of recruitment and maturation
prior to establishing a stable population of preovulatory
follicles. The apparent ability, shown in this study, of pro-
gesterone to mature stage I, II oocytes to stage IV oocytes
should also increase oocyte numbers and their viability in
anurans kept under conditions which have not resulted in
the entrainment of follicle maturity. The use of progester-
one should also promote greater oocyte numbers in
anurans with mature follicles, as even with natural spawn-
ing there are a substantial number of stage I and II imma-
ture oocytes [27,28]. However, the dose of progesterone
needed to mature oocytes could depend on the degree of
follicle maturation. With the ovulation of northern leop-
ard frogs reduced doses of progesterone in combination
with pituitaries was required for the induction of ovula-
tion as the breeding season progressed [29] Further assess-
ment of the relationship between dosage of progesterone
and the degree of follicular maturation in improving
oocytes numbers and quality with a seasonal reproducing
species could advance captive breeding protocols for
endangered amphibians. In anurans, some studies have
shown success in the non-invasive assessment of gonadal
maturation through ultrasound [30], although others
have considered the invasive method of biopsy more
accurate [31]. In fish biopsy performed through the cloaca
is the standard method for assessing gonadal maturity
[32].
The substantial number of oocytes not cleaving, and the
subsequent failure of many cleaved eggs to develop to
neurulation could be the result of a high percentage of
degenerate oocytes in the post-spawning females. Con-
comitant with the loss of stage VI oocytes during the
spawning season there is an increase in the amount of
degenerated (atresic) oocytes from the normal levels
found throughout the rest of the spawning cycle [27,28]
due to declines in gonadotrophin levels [33-35]. This pat-
tern of the seasonal availability of oocytes could explain
the need for progesterone as a maturation promoter to
achieve oocyte production and improve oocyte quality.
Moreover, this might explain the inability of the ovulating
hormones LHRHa and hCG alone to achieve ovulation
[27]. Previous studies have shown that exogenous proges-
terone can result in egg maturation both in-vivo and in-
vitro [13,15,16]. Yet, in this study progesterone alone did
not result in spawning. It has also been shown in some
other studies, that progesterone alone or in high repeated
doses did not result in ovulation and may inhibit subse-
quent ovulation [13,16].
The highest numbers of oocytes were produced by a com-
bination of progesterone with 20 µg LHRHa and Pimiz-
ide™. A combination of 20 µg LHRHa alone or LHRHa
with Pimozide™ failed to induce substantial oocyte pro-
duction and the highest number of oocytes were produced
from the three progesterone with LHRHa treatments. This
suggests that progesterone matured oocytes within 15 hrs
of administration, thus, enabling LHRHa to initiate ovu-
lation. An interesting result of this study was the poor
response of all treatments to the normal ovulatory dose of
hCG or LHRHa given after 24 or 48 hrs. In-vitro studies
have also shown that the oocytes of unstimulated Xenopus
laevis  females when exposed to progesterone require
approximately 3 to 15 hrs to complete meiotic maturationReproductive Biology and Endocrinology 2006, 4:3 http://www.rbej.com/content/4/1/3
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[13]. These results match those of fish hatcheries where
after the initial ovulatory dose of hormones a second dose
at 24 hrs is seldom successful (Browne unpublished). The
decreased oocyte numbers and fertilization rate when
hCG (500IU) was combined with a high dose of LHRHa
(60 µg) in comparison to 60 µg of LHRHa alone, agrees
with another study where high doses of hormones
resulted in poor oocyte quality [10]. An interesting result
was the production of oocyte in one animal with 20 µg
LHRHa and 0.25 mg Pimozide™ when the same dose of
LHRHa alone did not result in oocyte production. Unfor-
tunately, because of the limited number of animals
Pimozide™ was not tested with 60 µg of LHRHa. Further
studies with high doses of LHRHa in combination with
progesterone and Pimozide™ but without hCG could
yield superior oocyte production and quality to those
tested in this study.
Conclusion
The results of this study have demonstrated the impor-
tance of progesterone administration for final oocytes
maturation prior to or simultaneous with hormonal
induction of ovulation with LHRHa in potentially asea-
sonal animals. This combination of hormones promises
to increase the efficiency of aseasonal artificial ovulation
of captive anurans without adequate environmental
entrainment. Furthermore, in-vitro  fertilization studies
could also benefit from the provision of more oocytes of
greater viability, especially in cases where the genetic man-
agement of small captive populations of endangered
amphibians is crucial.
A major limiting factor in the use of hormones and other
compounds for the artificial ovulation of anurans in cap-
tivity is a scarcity of stage II to IV oocytes [6,27]. The devel-
opment of these oocytes is entrained seasonally in many
species or in other species by stoichasitic rainfall events
[27]. Therefore the limited reproductive success for many
anuran species in captivity, even with dedicated hus-
bandry programs, demands the creation of hormonal pro-
tocols for artificial ovulation which circumvent the
natural processes of oocyte recruitment [10]. The results
of this study have demonstrated the importance of proges-
terone administration for final oocyte maturation in-vivo
prior to, or simultaneous with, hormonal inducation of
ovulation with LHRHa in potentially aseasonal animals.
This combination of hormones promises to increase the
efficacy of aseasonal artificial ovulation of captive anurans
without adequate environmental entrainment. Further-
more, in-vitro fertilization studies could also benefit from
the provision of more oocytes of greater viability, espe-
cially in cases where the genetic management of small
captive populations of endangered amphibians is crucial.
The ability to promote final maturation of oocytes using
hormone therapy is particularly valuable considering
hibernation protocols for captive amphibians can often
cause bacterial and fungal infections that lead to death.
Our results suggest that progestone can mature oocytes
from previously spawned females and in combination
with LHRHa (20–60 µg) may be optimal for the induction
of ovulation, spawning, and the production of fertilizable
oocytes. Moreover, these results also suggest that if
sequential doses of hormones using progesterone are to
mature oocytes they may have to be implemented more
than 24 hrs and perhaps more than 48 hrs before the final
ovulatory dose. Further studies in this area are warranted
and are being investigated by our laboratory.
A promising technology for the aseasonal maturation of
oocytes is the use of implants to release hormones in a
controlled manner [36,37]. Two methods commonly
used for the sustained release of hormones are cholesterol
implants for both steroids and proteins [36] and mini-pel-
lets for proteins including LHRHa [37]. The sustained
administration of progesterone in-vivo has already been
shown to increase the maturation of oocytes and its
potential to increase the number of mature oocytes in
amphibians through slow release implants should be
investigated. The use of other hormone agonists besides
Pimozide™ or the identification of unknown agents in
pituitaries could also hold promise [18,20].
Table 4: Variables measured in response to a second administration of hormones 24 to 48 hrs after the first set of treatments include 
the number and percentage of spawning toads, the number of eggs, percentage fertilization, number of neurulas, percentage 
neurulation, and total number of neurulas. Data in the table are expressed as Means ± SE and ranges of spawning toads.
Treatment Treatment % Spawn No. oocytes % cleavage Neurulas % neurulation Total neurulas
8 500 IU hCG + 4 µg LHRHa 0/7 0% NA NA NA NA NA
96 0   µg LHRHa 0/7 0% NA NA NA NA NA
10 60 µg LHRHa 0/7 0% NA NA NA NA NA
11 60 µg LHRHa 1/7 14% 200 87% 0 0% 0
12 500 IU hCG 3/7 42% 68 ± 50 (13–110) 0% 0 0% 0
13 500 IU hCG 2/7 29% 160 ± 28 (60–100) 0% 0 0% 0
14* 60 µg LHRHa 0/5 0% NA NA NA NA NAReproductive Biology and Endocrinology 2006, 4:3 http://www.rbej.com/content/4/1/3
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